On ECHEMI
Home > Drugs > Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.

  • Founded in:

    2003-04-02
  • Country:

    China China
  • Address:

    Hanyu Innovation Industry Building, No. 7 Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen
  • Tax NO.:

    91440300748855818E
  • Registered Funds:

    883.241336 million yuan
  • Website:

  • Email:

Related Drugs
Eptifibatide
Name Description Content CAS NO. Registered Holders
Eptifibatide

188627-80-7 23
Carbetocin injection
Name Description Content CAS NO. Registered Holders
Carbetocin

Extract from the above information

More

Extract from the above information

37025-55-1 14
Carbetocin
Name Description Content CAS NO. Registered Holders
Carbetocin

Extract from the above information

More

Extract from the above information

37025-55-1 14
Thymopentin for injection
The main ingredient of this product is thymopentin, and the auxiliary materials are mannitol and hydrochloric acid
Name Description Content CAS NO. Registered Holders
Thymopentin

An immune bidirectional regulatory drug that induces and promotes the differentiation, maturation and activation of T lymphocytes and their subsets, regulates the proportion of T lymphocytes, enhances the body's cellular immune function, prompts T lymphocytes to secrete lymphokines, increases the level of lymphokine receptors on T cells, activates T helper cells to enhance lymphocyte responses, affects the chemotaxis of NK precursor cells and increases their cytotoxicity, and enhances the body's ability to resist radiation.

More

An immune bidirectional regulatory drug that induces and promotes the differentiation, maturation and activation of T lymphocytes and their subsets, regulates the proportion of T lymphocytes, enhances the body's cellular immune function, prompts T lymphocytes to secrete lymphokines, increases the level of lymphokine receptors on T cells, activates T helper cells to enhance lymphocyte responses, affects the chemotaxis of NK precursor cells and increases their cytotoxicity, and enhances the body's ability to resist radiation.

69558-55-0 41
Thymopentin
Name Description Content CAS NO. Registered Holders
Thymopentin

Extract from the above information

More

Extract from the above information

69558-55-0 41
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.